Hwang Eun-Ha, Hur Gyeung Haeng, Koo Bon-Sang, Oh Hanseul, Kim Green, Jung Hoyin, Baek Seung Ho, An You Jung, Park Jong-Hwan, Hong Jung Joo
National Primate Research Centre, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Chungcheongbuk, Republic of Korea.
Laboratory Animal Medicine, College of Veterinary Medicine, Chonnam National University, Gwangju, South Jeolla, Republic of Korea.
Heliyon. 2022 Oct 21;8(10):e11212. doi: 10.1016/j.heliyon.2022.e11212. eCollection 2022 Oct.
Dengue viruses (DENVs) exploit monocytes and macrophages for tropism and replication, therefore, establishing a long-term reservoir. However, their roles in dengue pathogenesis remains unclear. Here, using the human monocytic cell line THP-1, human primary monocytes, and non-human primate models, we show that DENV-infected monocytes represent suitable carriers for circulatory viral dissemination. Monocyte-derived macrophages expressing M2 surface markers at the gene level efficiently replicated, while the productivity of monocyte replication was low. However, attachment of DENVs to the cellular surface of monocytes was similar to that of macrophages. Furthermore, after differentiation with type-2 cytokines, DENV-attached monocytes could replicate DENVs. Productive DENV infection was confirmed by intravenous injection of DENVs into nonhuman primate model, in which, DENV attachment to monocytes was positively correlated with viremia. These results provide insight into the role of circulating monocytes in DENV infection, suggesting that monocytes directly assist in DENV dissemination and replication during viremia and could be applied to design antiviral intervention.
登革病毒(DENVs)利用单核细胞和巨噬细胞实现嗜性和复制,因此建立了一个长期储存库。然而,它们在登革热发病机制中的作用仍不清楚。在这里,我们使用人类单核细胞系THP-1、人类原代单核细胞和非人类灵长类动物模型,表明感染登革病毒的单核细胞是循环病毒传播的合适载体。在基因水平上表达M2表面标志物的单核细胞衍生巨噬细胞能高效复制,而单核细胞的复制效率较低。然而,登革病毒附着于单核细胞的细胞表面的情况与巨噬细胞相似。此外,在用2型细胞因子分化后,附着有登革病毒的单核细胞能够复制登革病毒。通过将登革病毒静脉注射到非人类灵长类动物模型中证实了登革病毒的有效感染,其中,登革病毒与单核细胞的附着与病毒血症呈正相关。这些结果为循环单核细胞在登革病毒感染中的作用提供了见解,表明单核细胞在病毒血症期间直接协助登革病毒的传播和复制,并可应用于设计抗病毒干预措施。